WASHINGTON - The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity disorder in children. Called Daytrana, the patch is designed to be worn for nine hours and ...
Four strengths of Daytrana prescription patches, worn to help children and adolescents diagnosed with ADHD, have been recalled nationwide by Noven Pharmaceuticals’ Miami office. The reason given on ...
NEW YORK (Reuters Health) - Smoking during pregnancy has been linked to a higher chance of the child having attention-deficit/hyperactivity disorder (ADHD), and a new ...
BOSTON – OCTOBER 25, 2007 – Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that data from a 12-month study of DAYTRANATM (methylphenidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results